SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-13-002662
Filing Date
2013-01-15
Accepted
2013-01-15 16:16:36
Documents
5
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A a13-2938_110qa.htm 10-Q/A 67759
2 EX-10.2 a13-2938_1ex10d2.htm EX-10.2 951548
3 EX-31.1 a13-2938_1ex31d1.htm EX-31.1 5316
4 EX-31.2 a13-2938_1ex31d2.htm EX-31.2 5032
5 GRAPHIC g29381bai001.jpg GRAPHIC 11093
  Complete submission text file 0001104659-13-002662.txt   1046079
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-23272 | Film No.: 13530692
SIC: 2836 Biological Products, (No Diagnostic Substances)